Published in Phys Med Biol on December 07, 2015
Applications and limitations of radiomics. Phys Med Biol (2016) 0.85
Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments. Neuroimage Clin (2016) 0.76
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol (2010) 24.32
From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med (2009) 12.92
Partial-volume effect in PET tumor imaging. J Nucl Med (2007) 5.81
Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys (1997) 4.73
A tabulated summary of the FDG PET literature. J Nucl Med (2001) 4.37
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun (2014) 4.16
Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys (1989) 3.77
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res (2005) 3.71
Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med (2011) 3.66
Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer (2012) 3.56
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. Pattern Recognit (2009) 3.32
Radiomics: the process and the challenges. Magn Reson Imaging (2012) 2.65
Comparative assessment of methods for estimating tumor volume and standardized uptake value in (18)F-FDG PET. J Nucl Med (2010) 2.54
Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. Clin Positron Imaging (1999) 2.43
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med (2012) 2.13
Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome. J Nucl Med (2008) 1.86
Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Radiology (2012) 1.75
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis. Eur J Nucl Med Mol Imaging (2012) 1.75
Resolution modeling in PET imaging: theory, practice, benefits, and pitfalls. Med Phys (2013) 1.69
A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology. Phys Med Biol (2012) 1.67
Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies. Eur J Nucl Med Mol Imaging (2011) 1.63
Noise considerations for PET quantification using maximum and peak standardized uptake value. J Nucl Med (2012) 1.62
NEMA NU 2-2001 performance measurements of an LYSO-based PET/CT system in 2D and 3D acquisition modes. J Nucl Med (2006) 1.56
The origins and implications of intratumor heterogeneity. Cancer Prev Res (Phila) (2010) 1.55
18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med (2014) 1.52
The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys (2012) 1.46
Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med (2014) 1.43
Clinically relevant optimization of 3-D conformal treatments. Med Phys (1992) 1.42
Tumor-specific positron emission tomography imaging in patients: [18F] fluorodeoxyglucose and beyond. Clin Cancer Res (2007) 1.40
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging Med (2012) 1.32
Performance evaluation of the new whole-body PET/CT scanner: Discovery ST. Eur J Nucl Med Mol Imaging (2004) 1.28
A novel fuzzy C-means algorithm for unsupervised heterogeneous tumor quantification in PET. Med Phys (2010) 1.28
Visual versus quantitative assessment of intratumor 18F-FDG PET uptake heterogeneity: prognostic value in non-small cell lung cancer. J Nucl Med (2014) 1.23
Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. Acad Radiol (2012) 1.21
Quantifying heterogeneity in human tumours using MRI and PET. Eur J Cancer (2012) 1.20
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Acad Radiol (2012) 1.16
Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma. J Nucl Med (2012) 1.14
Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. Semin Nucl Med (2007) 1.06
Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer. J Nucl Med (2012) 1.04
Molecular imaging biomarkers for oncology clinical trials. J Nucl Med (2014) 1.03
Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors. Neoplasia (2000) 1.01
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. J Nucl Med (2013) 1.00
Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET. Int J Radiat Oncol Biol Phys (2012) 0.96
False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review. PLoS One (2015) 0.96
Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy. Eur J Nucl Med Mol Imaging (2012) 0.95
From patient-specific mathematical neuro-oncology to precision medicine. Front Oncol (2013) 0.95
Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma. Oral Oncol (2012) 0.91
PET quantification with a histogram derived total activity metric: superior quantitative consistency compared to total lesion glycolysis with absolute or relative SUV thresholds in phantoms and lung cancer patients. Nucl Med Biol (2014) 0.88
The generalized equivalent uniform dose function as a basis for intensity-modulated treatment planning. Phys Med Biol (2002) 0.87
How to assess background activity: introducing a histogram-based analysis as a first step for accurate one-step PET quantification. Nucl Med Commun (2014) 0.85
Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma. AJR Am J Roentgenol (2014) 0.84
Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging. AJR Am J Roentgenol (2015) 0.84
FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma. AJR Am J Roentgenol (2014) 0.81
Influence of ROI definition, partial volume correction and SUV normalization on SUV-survival correlation in oesophageal cancer. Nucl Med Commun (2010) 0.80
Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status. Head Neck (2014) 0.78
Partial Volume Correction Strategies in PET. PET Clin (2008) 0.77
Contourlet-based active contour model for PET image segmentation. Med Phys (2013) 0.76
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA (2009) 9.47
Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys (2010) 4.33
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys (2010) 3.83
Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys (2010) 3.73
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (2008) 3.61
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2002) 2.76
Precise radiochromic film dosimetry using a flat-bed document scanner. Med Phys (2005) 2.63
Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol (2007) 2.56
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys (2010) 2.32
Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data. Biophys J (2008) 2.27
The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis. Genes Chromosomes Cancer (2003) 2.24
Telomeric expression sites are highly conserved in Trypanosoma brucei. PLoS One (2008) 2.22
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol (2008) 2.08
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys (2005) 2.02
Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases. Int J Radiat Oncol Biol Phys (2009) 1.97
Equatorially dominated magnetic field change at the surface of Earth's core. Science (2003) 1.94
GeneDB--an annotation database for pathogens. Nucleic Acids Res (2011) 1.82
Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res (2009) 1.69
FGF9 suppresses meiosis and promotes male germ cell fate in mice. Dev Cell (2010) 1.64
18F-FDG metabolic tumor volume and total glycolytic activity of oral cavity and oropharyngeal squamous cell cancer: adding value to clinical staging. J Nucl Med (2012) 1.57
Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer (2005) 1.57
Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2004) 1.56
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys (2010) 1.46
The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys (2012) 1.46
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys (2010) 1.44
A novel small-angle neutron scattering detector geometry. J Appl Crystallogr (2013) 1.39
Estimating the volume of chronic pleural effusions using transesophageal echocardiography. J Cardiothorac Vasc Anesth (2011) 1.39
Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT. J Comput Assist Tomogr (2007) 1.38
An autonomous implantable computer for neural recording and stimulation in unrestrained primates. J Neurosci Methods (2005) 1.38
Learning a novel myoelectric-controlled interface task. J Neurophysiol (2008) 1.36
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. Imaging Med (2012) 1.32
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer (2006) 1.28
Pharmacokinetic assessment of the uptake of 16beta-18F-fluoro-5alpha-dihydrotestosterone (FDHT) in prostate tumors as measured by PET. J Nucl Med (2010) 1.27
Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging. Phys Med Biol (2009) 1.22
Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med (2011) 1.22
Seven consecutive successful clinical islet isolations with pancreatic ductal injection. Cell Transplant (2009) 1.21
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys (2002) 1.20
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med (2007) 1.19
Brachial plexus contouring with CT and MR imaging in radiation therapy planning for head and neck cancer. Radiographics (2010) 1.15
Flexible cortical control of task-specific muscle synergies. J Neurosci (2012) 1.14
Reanimating the arm and hand with intraspinal microstimulation. J Neural Eng (2011) 1.12
Calcineurin/nuclear factor of activated T cells and MAPK signaling induce TNF-{alpha} gene expression in pancreatic islet endocrine cells. J Biol Chem (2010) 1.12
Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy. Ann Nucl Med (2012) 1.10
The finished DNA sequence of human chromosome 12. Nature (2006) 1.08
Intensity-modulated radiotherapy. Cancer J (2002) 1.07
Iodixanol-controlled density gradient during islet purification improves recovery rate in human islet isolation. Transplantation (2009) 1.07
Slower Walking Speed Forecasts Increased Postoperative Morbidity and 1-Year Mortality Across Surgical Specialties. Ann Surg (2015) 1.07
Surgical Ward Round Quality and Impact on Variable Patient Outcomes. Ann Surg (2015) 1.07
The Genboree Microbiome Toolset and the analysis of 16S rRNA microbial sequences. BMC Bioinformatics (2012) 1.05
Increased water retention in polymer electrolyte membranes at elevated temperatures assisted by capillary condensation. Nano Lett (2007) 1.04
Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Int J Radiat Oncol Biol Phys (2006) 1.04
PET/CT of cancer patients: part 1, pancreatic neoplasms. AJR Am J Roentgenol (2012) 1.02
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma (2008) 1.02
Evolving role of FDG PET/CT in multiple myeloma imaging and management. AJR Am J Roentgenol (2013) 1.01
Low-temperature preservation of isolated islets is superior to conventional islet culture before islet transplantation. Transplantation (2010) 1.01
Abstract and proportional myoelectric control for multi-fingered hand prostheses. Ann Biomed Eng (2013) 1.01
Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys (2012) 1.00
Fresh islets are more effective for islet transplantation than cultured islets. Cell Transplant (2012) 1.00
Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol (2003) 1.00
Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. Radiother Oncol (2002) 1.00
Characterization and gene expression analysis of the cir multi-gene family of Plasmodium chabaudi chabaudi (AS). BMC Genomics (2012) 0.99
FDG PET/CT in patients with HIV. AJR Am J Roentgenol (2011) 0.99
Value of PET/CT in the management of primary hepatobiliary tumors, part 2. AJR Am J Roentgenol (2011) 0.99
Value of PET/CT in the management of liver metastases, part 1. AJR Am J Roentgenol (2011) 0.98
PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma. AJR Am J Roentgenol (2013) 0.98
Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma. AJR Am J Roentgenol (2011) 0.97
Thrombotic microangiopathy associated with interferon beta. N Engl J Med (2014) 0.97
Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. Int J Radiat Oncol Biol Phys (2011) 0.95
Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol (2009) 0.95
The effects of chronic social defeat stress on mouse self-grooming behavior and its patterning. Behav Brain Res (2010) 0.95
Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis. Mayo Clin Proc (2008) 0.94
FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site. Nucl Med Commun (2012) 0.94
Reduced-order parameter optimization for simplifying prostate IMRT planning. Phys Med Biol (2007) 0.94
FDG PET/CT in the management of nasopharyngeal carcinoma. AJR Am J Roentgenol (2014) 0.94
Endogenous Nodal signaling regulates germ cell potency during mammalian testis development. Development (2012) 0.94
Liver SULmean at FDG PET/CT: interreader agreement and impact of placement of volume of interest. Radiology (2013) 0.93
Secondary prevention interventions for young drug users: a systematic review of the evidence. Adolescence (2005) 0.93
Characterization of human pancreatic progenitor cells. Cell Transplant (2010) 0.93
Oncologic 18F-FDG PET/CT: referring physicians' point of view. J Nucl Med (2012) 0.93
Comparison of ulinastatin, gabexate mesilate, and nafamostat mesilate in preservation solution for islet isolation. Cell Transplant (2012) 0.92
Cystic and cystic-appearing lesions of the mandible: review. AJR Am J Roentgenol (2011) 0.92
SUITO index for evaluation of efficacy of single donor islet transplantation. Cell Transplant (2009) 0.92
CXCR4/SDF1 interaction inhibits the primordial to primary follicle transition in the neonatal mouse ovary. Dev Biol (2006) 0.92
Ductal injection of JNK inhibitors before pancreas preservation prevents islet apoptosis and improves islet graft function. Hum Gene Ther (2009) 0.92
Modulation of antitumor responses by dendritic cells. Springer Semin Immunopathol (2005) 0.91
Reduced-order constrained optimization in IMRT planning. Phys Med Biol (2008) 0.90
Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA. Biomaterials (2011) 0.90
From radical mastectomy to breast-conserving therapy and oncoplastic breast surgery: a narrative review comparing oncological result, cosmetic outcome, quality of life, and health economy. ISRN Oncol (2013) 0.90
Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters. AJR Am J Roentgenol (2012) 0.90
Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake. Radiology (2010) 0.90
FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors. Clin Nucl Med (2014) 0.90
Rectal motion can reduce CTV coverage and increase rectal dose during prostate radiotherapy: A daily cone-beam CT study. Radiother Oncol (2008) 0.89
Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus. FEMS Microbiol Lett (2011) 0.89
Improvement of pancreatic islet cell isolation for transplantation. Proc (Bayl Univ Med Cent) (2007) 0.89